Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.81
-0.06 (-3.21%)
At close: Oct 16, 2025, 3:59 PM
1.88
3.87%
After-hours: Oct 16, 2025, 07:30 PM EDT
-3.21% (1D)
| Bid | 1.8 |
| Market Cap | 65.07M |
| Revenue (ttm) | 82.24K |
| Net Income (ttm) | -18.59M |
| EPS (ttm) | -0.59 |
| PE Ratio (ttm) | -3.07 |
| Forward PE | -2.72 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.96 |
| Volume | 704,348 |
| Avg. Volume (20D) | 579,892 |
| Open | 1.86 |
| Previous Close | 1.87 |
| Day's Range | 1.77 - 1.90 |
| 52-Week Range | 1.41 - 3.19 |
| Beta | 0.12 |
| Ex-Dividend Date | n/a |
About GANX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GANX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GANX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+15.63%
Gain Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
